Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Andreoni

Showing results (271-280 of 306) with videos related to

Pageof 31
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2014
Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levelsMaria Mercedes Santoro, Lavinia Fabeni, Daniele Armenia, et al.
Hepatology (Baltimore, Md.)|November 25, 2014
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppressionRomina Salpini, Luna Colagrossi, Maria Concetta Bellocchi, et al.
The Journal of Infection|June 26, 2013
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigenValeria Cento, Formijn Van Hemert, Maria Neumann-Fraune, et al.
Viruses|August 26, 2023
Frequency of Atypical Mutations in the Spike Glycoprotein in SARS-CoV-2 Circulating from July 2020 to July 2022 in Central Italy: A Refined Analysis by Next Generation SequencingMaria Concetta Bellocchi, Rossana Scutari, Luca Carioti, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|October 16, 2023
Parietal resting-state EEG alpha source connectivity is associated with subcortical white matter lesions in HIV-positive peopleClaudio Babiloni, Claudio Del Percio, Claudia Piervincenzi, et al.
Viruses|February 28, 2020
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in VitroRomina Salpini, Lorenzo Piermatteo, Arianna Battisti, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 10, 2020
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settingsDaniele Armenia, Yagai Bouba, Roberta Gagliardini, et al.
Advances in Therapy|October 29, 2024
Updated Results from the Retrospective CREST Study on the Safety and Effectiveness of 8-Week Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated CirrhosisMarkus Cornberg, Dietrich Hüppe, Christoph Sarrazin, et al.
Antiviral Therapy|April 13, 2019
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimenDaniele Armenia, Domenico Di Carlo, Alessandro Cozzi-Lepri, et al.
Antiviral Therapy|January 25, 2013
Impact of pre-therapy viral load on virological response to modern first-line HAARTMaria Mercedes Santoro, Daniele Armenia, Claudia Alteri, et al.
Pageof 31

Showing results (271-280 of 306) with videos related to

Sort By:
Pageof 31
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2014
Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levelsMaria Mercedes Santoro, Lavinia Fabeni, Daniele Armenia, et al.
Hepatology (Baltimore, Md.)|November 25, 2014
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppressionRomina Salpini, Luna Colagrossi, Maria Concetta Bellocchi, et al.
The Journal of Infection|June 26, 2013
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigenValeria Cento, Formijn Van Hemert, Maria Neumann-Fraune, et al.
Viruses|August 26, 2023
Frequency of Atypical Mutations in the Spike Glycoprotein in SARS-CoV-2 Circulating from July 2020 to July 2022 in Central Italy: A Refined Analysis by Next Generation SequencingMaria Concetta Bellocchi, Rossana Scutari, Luca Carioti, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|October 16, 2023
Parietal resting-state EEG alpha source connectivity is associated with subcortical white matter lesions in HIV-positive peopleClaudio Babiloni, Claudio Del Percio, Claudia Piervincenzi, et al.
Viruses|February 28, 2020
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in VitroRomina Salpini, Lorenzo Piermatteo, Arianna Battisti, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 10, 2020
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settingsDaniele Armenia, Yagai Bouba, Roberta Gagliardini, et al.
Advances in Therapy|October 29, 2024
Updated Results from the Retrospective CREST Study on the Safety and Effectiveness of 8-Week Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated CirrhosisMarkus Cornberg, Dietrich Hüppe, Christoph Sarrazin, et al.
Antiviral Therapy|April 13, 2019
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimenDaniele Armenia, Domenico Di Carlo, Alessandro Cozzi-Lepri, et al.
Antiviral Therapy|January 25, 2013
Impact of pre-therapy viral load on virological response to modern first-line HAARTMaria Mercedes Santoro, Daniele Armenia, Claudia Alteri, et al.
Pageof 31